SUPPLY OF MEDICAL DEVICE: ABSORBABLE HEMOSTAT OF OXIDIZED AND REGENERATED CELLULOSE FROM FIBROUS TISSUE

This tender, identified as LP-ABR-83-2025-INSN-SB-1, concerns the supply of a specific medical device: an absorbable hemostat made from oxidized and regenerated cellulose derived from fibrous tissue. The contracting entity is the National Institute of Child Health - San Borja (INSTITUTO NACIONAL DE SALUD DEL NIÑO - SAN BORJA), located in the Lima department. The procurement method selected for this process is an Abbreviated Public Tender (Licitación Pública Abreviada), suggesting a streamlined bidding process. The core requirement is the provision of this specialized hemostatic agent, which is designed to control bleeding during surgical procedures and is characterized by its absorbability and composition. While the description is concise, it implies a need for a high-quality, reliable medical product that meets specific technical standards for use in a pediatric healthcare setting. Further details regarding the exact specifications, quantities, delivery timelines, and evaluation criteria would typically be found in the full tender documentation. This opportunity is relevant for suppliers specializing in medical devices and surgical consumables, particularly those with expertise in hemostatic agents. The tender is issued by a prominent national health institution, indicating a significant procurement volume and the potential for a valuable contract within the Peruvian healthcare sector.

This is a supplies contract in the governance and public administration sector. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 340,800.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.